Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?

Key Points

• Centrus Energy completed a $116 million acquisition of Westerman Holdings on Oct. 16 to secure its primary centrifuge-component manufacturing supply chain.
• Despite falling nearly 55% year-to-date on dilution concerns from a $500 million stock offering, Centrus holds a $3.7 billion uranium enrichment backlog and a $900 million Department of Energy contract.
• Zacks Research upgraded Centrus to Strong-Buy with a consensus price target near $225, implying over 100% upside as nuclear fuel demand grows.

The artificial intelligence (AI) revolution faces a physical constraint: electricity. Hyperscale data centers require uninterrupted, carbon-free baseload power that intermittent renewables struggle to provide. This reality has triggered a historic renaissance in nuclear energy, specifically accelerating the deployment of small modular reactors.

Building reactors is only half the equation. Securing the specialized fuel to run them is yet another bottleneck.

Centrus Energy Corp. NYSE: LEU is a key player in the domestic supply chain for next-generation nuclear fuel. Recent strategic moves indicate Centrus is actively integrating its operations to strengthen its position in this emerging supply chain. Investors may want to note how recent market reactions have created a potential disconnect between short-term price action and long-term infrastructure capabilities.

Fusing Assets: The Westerman Acquisition

To understand the ongoing shift, investors need to look at the recent acquisition of Westerman Holdings.

On Oct. 16, Centrus completed its acquisition of the legacy industrial fabricator and primary centrifuge-component supplier for approximately $116 million.

The funding structure consisted of about $95 million in cash and roughly $21 million in equity. Bringing its largest component supplier in-house secures the critical manufacturing base required for a multi-billion-dollar expansion of uranium enrichment capacity.

Supply chain bottlenecks represent a significant risk in nuclear infrastructure development. The industry cannot afford delays caused by third-party vendor constraints.

By owning Westerman, Centrus gains greater control over the manufacturing timelines for centrifuge casings and other major components. Management projects the acquisition will yield commercial efficiencies, lower project costs, and become accretive to adjusted earnings per share within the first year.

Beyond nuclear infrastructure, Westerman services non-nuclear sectors. The fabrication business provides a broad portfolio of products spanning upstream and midstream oil and gas production equipment. This helps diversify revenue streams, allowing Centrus to generate cash flow from high-growth industrial sectors while it waits for the broader nuclear renaissance to fully mature.

Dilution Fears Cloud the Nuclear Strategy

Wall Street often struggles to price long-term infrastructure investments accurately, focusing heavily on immediate capital outlays. After the acquisition announcement, Centrus Energy’s stock price fell about 4% and hovered near the 52-week low.

Year-to-date, Centrus stock has fallen nearly 55%. The stock currently trades at a trailing price-to-earnings ratio of about 52, with a forward multiple closer to 26, reflecting expectations of significant earnings growth. Despite these growth projections, the market capitalization sits at just over $2 billion.

Investors may have focused more on the $95 million reduction in cash reserves and the modest dilution from the equity portion of the deal than on the long-term benefits of securing its supply chain. Pinning the recent weakness entirely on the Westerman deal ignores the broader technical context.

A significant driver of recent negative price action stems from a $500 million underwritten public offering of Class A common stock and warrants priced in early September. This substantial capital raise introduced significant potential dilution through the issuance of common stock and warrants, adding pressure to the stock's already weakened momentum.

The market appears to be punishing Centrus for consecutive dilutive events, with near-term selling pressure overshadowing the long-term strategic benefits of the Westerman acquisition. Mid-October filings have shown institutional divestment, such as advisory firm TB Alternative Assets Ltd.'s unloading of over 66,000 shares.

The broader market is demanding immediate profitability, while Centrus is aggressively transforming its capital structure to achieve decade-long dominance.

Critical Mass: A Multi-Billion Dollar Moat

Looking past the recent multiple compressions requires examining the underlying business fundamentals.

generated approximately $77.8 million in net income in 2025, demonstrating that it already operates a profitable business as it invests in expanding domestic uranium enrichment capacity. The true value lies in future revenue visibility. Centrus sits on a substantial $3.7 billion backlog for low-enriched uranium.

Added to this is a recent $900 million contract with the Department of Energy for high-assay low-enriched uranium. This specific fuel is enriched up to 20%, compared to the 5% used in traditional reactors. It is required for many advanced reactor designs, including some small modular reactors and microreactors. This level of government backing and revenue visibility helps to reduce the financial risk associated with the cash outlay for Westerman Holdings.

The demand side of the equation is also firming up rapidly. In September, Centrus locked in multi-year supply contracts with advanced microreactor developers Antares and Radiant.

These binding agreements provide long-term commercial demand for the scaled manufacturing capacity that Westerman provides.

Analysts appear to recognize this fundamental runway. Despite the bearish retail sentiment and short-term technical damage, research firms maintain a constructive outlook.

Zacks Research recently upgraded the stock to a Strong-Buy rating, and the consensus price target hovers around $225, suggesting potential upside of over 100% from current levels.

The Next Phase of Nuclear Infrastructure

The nuclear supply chain requires rapid vertical integration to meet the surging energy demands of the technology sector. Integrating a major component manufacturer ensures the physical infrastructure is in place to scale production with reduced reliance on external suppliers for critical centrifuge components.

Securing domestic centrifuge manufacturing can be a competitive advantage in an industry with significant technical and regulatory barriers to entry. It is nearly impossible for a new entrant to replicate the engineering expertise, regulatory approvals, and manufacturing footprint that Centrus is currently assembling.

While integration risks and depleted cash reserves remain valid near-term concerns, macroeconomic tailwinds from AI energy demand are accelerating. Investors focusing solely on recent equity dilution might be missing a much larger structural shift in the physical economy.

The combination of a multi-billion-dollar backlog, federal backing, and a newly secured manufacturing base positions Centrus to strengthen its position in a critical segment of the domestic energy supply chain.

Cautious investors might prefer to wait for a technical stabilization before taking a position, as the overhang from the recent capital raises could continue to pressure the share price in the near term. Those with a higher risk tolerance seeking exposure to the physical infrastructure powering the next decade of technological growth might add Centrus to their watchlists as the enterprise navigates its current capital transformation.